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INTRODUCTION
Amygdalin is one of the earliest of plant products
which have been used for cancer treatment.

As far back

as 2800 B.C. in the time of the Pen T'sao (Great Chinese
Herbal) of ancient China these Prunus species and other
amygdalin bearing plants have been in medical use (Halstead,
1977).

The precise mechanism of action of amygdalin is

not known but several hypotheses have been proposed (Brekman
and Dardymov, 1969; Krebs, 1970; Brewer and Passwater,
1976).
Amygdalin is a cyanogenic glycoside derived from
the kernels of various fruits of the genus Prunus (synonym
amygdalus).

When amygdalin is hydrolyzed it yields glucose,

benzaldehyde and hydrogen cyanide (Montgomery, 1969).
Due to its plant origin, chemical composition and
theoretical antineoplastic effects it has been attributed
to a number of functions.

It has been identified as a

food product (Montgomery, 1969), a vitamin (Krebs, 1970),
a cancer agent (Wodinsky and Swiniarski, 1975) and an
analgesic (Halstead, 1977).

The hydrogen cyanide released

from amygdalin has been theorized as exerting selective
anticancer effects by Ernst T. Krebs, Jr. in 1952.

1

The
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release and specificity of cyanide is due to certain enzymes
present in the body (Viehover and Mack, 1935).
In the early 1900's Ernst T. Krebs, Sr., a physician
and pharmacist, developed an apricot extract which contained
enzymes with unusual biochemical properties.

His

experimentation with this extract on cancer tissue was
later reported toxic and only partially effective (Culbert,
1976).

Krebs, Jr. followed his father's dedication to

medicine and pharmacy.

It was his reasearch into John

Beard's Trophoblastic Thesis of Cancer that led him to
the investigation of the effects of enzymes on cancer.
Beard's theory (1902) pointed to the similar properties
pregnancy trophoblast cells and cancer cells shared.

He

believed because of these similarities trophoblast cells
and cancer cells were identical.

From these observations,

Krebs, Jr., Krebs, Sr. and H. Beard (1950) eventually
proposed that it was the pancreatic enzymes which causes
the destruction of the pregnancy trophoblast cells.

This

led Krebs, Jr. to investigate the use of enzymes against
cancer.

Krebs claimed to have had partial success using

these enzymes but the enzymes alone lacked the effectiveness
Beard claimed in his theory (Culbert, 1976).
Krebs went back to his father's original apricot
extract and subsequently claimed to have synthesized betacyanophoric glucuronicide which in the presence of beta-

.....
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glucuronidase he postulated it released hydrogen cyanide.
This new compound was called Laetrile® for it was derived
from a laevo-rotary nitrile.

Cancer cells are rich in

enzymes beta-glucosidase and beta-glucuronidase which split
nitrilosides (organic compounds containing cyanide) and
liberate hydrogen cyanide (Haisman and Knight,
1967,

1970~

Culbert, 1974).

1967~

Krebs,

Krebs indicated that localized

high concentration of beta-glucuronidase present in cancer
cells facilitated the selective release of hydrogen cyanide
from Laetrile® at the cancer site which, in addition, is
almost totally devoid of the enzyme

~hodanese

which in

normal body cells detoxifies cyanide to thiocyanate (Krebs,
1970).

Thus, the end result is the selective destruction

of cancer cells.

Although attractive Kreb's hypothesis

about the mechanism of action of Laetrile® has not been
confirmed for the most part.
At present amygdalin is being used in cancer
therapy.

The main biochemical difference between it and

Kreb's Laetrile® is that amygdalin contains 2 glucose
molecules and Laetrile® has only 1.

Hydrolysis of amygdalin

by the enzyme beta-glucosidase to release hydrogen cyanide
has been scientifically documented (Haisman and Knight,
1967).

Therefore the current use of amygdalin for cancer

therapy is based upon the assumption of cyanide release
by the enzyme beta-glucosidase (Griffin, 1974).

4

The dosages of amygdalin found toxic to adult
animals by researchers are not uniform.

Amygdalin at

dosages as high as 10 gm/kg body weight were found to be
non-toxic to adult animals (Burk, 1971).

On the other

hand, Amygdalin MF (McNaughton Foundation) was found to
reduce the median survival time of mice 6-16% with dosages
ranging from 50-500 mg/kg (Hill and Shine, 1975).

Moreover,

Krebs (1970) has indicated that Laetrile is non-toxic at
dosages as high as 25,000 mg/kg body weight.

In our

laboratory toxicity studies with amygdalin which were
performed in adult mice, at dosages ranging from 1000-2500
mg/kg for 15 days, proved to be non-toxic (Manner, DiSanti
and Michalsen, 1977).

Hill et al (1976) found that

amygdalin at a dose of 2000 mg/kg for 4 days caused a 5%
death rate in adult mice.
The question of the teratogenic potential of this
controversial compound clearly warrants further
investigation due to the increasing number of people who
are choosing it for cancer therapy.

Teratology is the

scientific study of biological malformations produced during
the development of the organism.

Agents causing

malformations to developing embryos when administered to
mothers during their pregnancy are ordinarily harmless
to the adult animals themselves.

This is partially due

to the fact the fetus does not have the detoxifying

5

capabilities of the adult organism {DiPaolo, 1969).

The

development of a sound technique for verification of the
effects of these compounds on developing embryos has its
limitations because different species have different levels
of tolerances.

A good example of this is the Thalidomide

incident that took place in the 1960's.

Early testing

of this agent by Somers {1962), and Seller {1962) showed
that malformations occurred in rabbits but none in the
rat fetuses only reabsorptions were found, no external
abnormalities.

Later, it was also found to be teratogenic

to man (Lenz, 1966).

Additional testing of this drug

eventually showed to be teratogenic in the rat {King, 1962).
Thus, we cannot reliably utilize these data for a valid
comparison between laboratory animals and humans {Wilson,
1972).

The animal studies are valuable for they give us

a foundation on which to base further studies.

These type

of studies are the best available at the moment since human
trials are not an acceptable alternative without having
established some knowledge from prior animal testing
{Murphy, 1965).
Wilson {1965) additionally describes the
complexities of these studies.
embryonic and embryonic factors.

They involve both nonThe non-embryonic factors

are the physical environment of the embryo {maternal
organism), the agents mechanism of action and the dosage

6

levels.

The embryonic factors include the genotype of

the species tested and the developmental stages at which
the embryos are more susceptible to teratogenic actions.
The degree of susceptibility varies greatly during the
course of the animals gestational period.

In the very

early stages of the embryo's development when the dividing
cells are totipotent, destruction of a certain percentage
of these cells is not considered to be harmful.

The embryo

is able to make internal adjustments so growth and normal
development may continue.

The cleavage stage seems quite

resistant to teratogens but only to a point.

•

Once too

many of the totipotent cells have been damaged, the embryo
can not recover.

Teratogenic susceptibility is highest

during the time the germ layers are formed (day 5 in the
mouse and as early as the eleventh and twelfth day in
humans).

The highest incidence of malformations by a

variety of teratogens may occur shortly after this time
once localized areas acquire organ forming capabilities.
At this time chemically differentiated cells may be subject
to teratogenesis several hours or days before their role
in development is indicated by morphological
differentiation.

As differentiation and organogenesis

proceed the susceptibility of teratogenesis decreases.
Larger doses of the teratogen are also required to produce
similar malformations brought about earlier, and sometimes
similar ones cannot be brought about at all.

7

This teratogenic study of amygdalin administered
to pregnant mice is not designed to prove or disprove either
Kreb's "cyanide theory" or Beard's Trophoblastic Thesis
of Cancer.

Since amygdalin is theorized to attack cancer

cells, and since cancer cells are similar to trophoblast
cells as Beard and Krebs believe then the possibility of
trophoblastic damage by amygdalin administered to the
pregnant female needs to be examined.

In addition, this

study is designed to evaluate if amygdalin is toxic to
the developing embryo and fetus which may lead to abnormal
development.

Hopefully it will stimulate further studies,

so its possible effects on human embryos and fetuses can
be evaluated.

REVIEW OF RELATED LITERATURE
AMYGDALIN
Amygdalin was one of the first isolated cyanogenic
glycosides.

A glycoside is any natural plant or animal

compound that contains sugar.

A cyanogenic glycoside is

a compound containing sugar and having the capacity of
producing cyanogen or hydrocyanic acid (Halstead, 1977).
A list of the sources of cyanogenic glucosides (any
glycoside whose sugar constituent is glucose) which are
habitually consumed by man are cassava, sweet potato, yam,
maize, millet, bamboo, sugar cane, peas, beans, and kernel
of almond, lemon, lime, apple, pear, cherry, apricot, prune
and plum as well as about 150 other foods (Halstead, 1977).
Two French chemists, Robiquet and Boutron-Charland
isolated crystalline amygdalin in 1830.

The term amygdalin

comes from the scientific name of the bitter almond (
Amygdalin communis amara) from which much of the substance
is derived.

The Merk Index (1976) describes amygdalin

as D-mandelonitrile-B-D-glucosido-6-B-D-glucoside.
empirical formula is
of 457.42.

c20 H27 N11

The

and has a molecular weight

Its elemental composition is C 52.51%, H 5.95%,

8
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N 3.06% and 0 38.47%.
in figure 1.

The molecular structure can be seen

As early as 1935 Viehoever and Mack (1935)

demonostrated amygdalin's hydrolysis was possible by 2
methods.

One method, amygdalin is split by an emulsin

which contains an enzyme that yields glucose and
mandelonitrile glucoside.

~hese

are subsequently converted

by an enzyme in the emulsin with the final end products
being benzaldehyde, 2 glucose molecules and hydrogen
cyanide.

The other method is hydrolysis with hot dilute

mineral acids giving the same end products as the first
method.
Amygdalin is often referred to by the term Laetrile
however they are not chemically synonymous compounds.
The term Laetrile derived from the chemical term laevomandelo-nitrile was first proposed by Ernst T. Krebs, Jr.

~1erck Index ( 1976) defines Laetrile® as 1-mandeloni trilea-glucuronic acid.

Its empirical formula is C14H15N07

and has a molecular weight of 309.27.

It's elemental

composition is C' 54.37%, H 4.89%, N 4.53% and 0 36.21%.
The molecular structure is shown in figure 2.
I,

'~

•

It may be

obtained by either hydrolysis of amygdalin and oxidation
of the resulting 1-mandelonitrile-B-glucoside with platinum
black or by the condensation of mandelonitrile with glucose
and subsequent oxidation; or by the condensation of
mandelonitrile with glucuronic acid according to Krebs,

10

H

OH

Figure 1

AMYGDALIN

COOH

CN
~-

H

I

o--CH--C H

OH

Figure 2

MOLECULAR STRUCTURES OF. AMYGDALIN AND LAETRILE
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Jr. and Krebs, Sr. who obtained the pat. 778,855 in 1958
for Laetrile® (Merk Index, 1976).

Confusion arises because

both these terms amygdalin and Laetrile are interchangeably
used in literature.
Ernst T. Krebs, Sr.'s extract of beta cyanogenic
glucoside was used in cancer treatment back in 1920.

Later

in 1953 his son, Ernst T. Krebs, Jr. claimed he had
synthesized a new Laetrile@ which he designated as betacyanophoric-glucuroniside because in the presence of any
enzyme beta-glucuronidase it released quantities of hydrogen
cyanide.

Since that time Krebs, Jr. has now designated

the term Laetrile to refer to any beta-cyanogenic glucosides
which includes amygdalin and any of its chemical derivatives
(Halstead, 1977).
PROPOSED MECHANISM OF ACTION OF AMYGDALIN
In the early 1950's the mechanism of action of
Amygdalin, often referred to as the "cyanide theory", was
proposed by Ernst T. Krebs, Jr.

His proposed mechanism

of action is still questionable but some evidence
substantiates certain aspects of his theory.

He originally

proposed that tumor tissue was high in the hydrolyzing
enzyme of amygdalin, beta-glucuronidase.

Data by Fishman

and Anlyan (1947a,b) confirms its high concentration in
tumor tissue.

When Laetrile reached the site of the tumor
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Krebs claimed that beta-glucuronidase cleaved the hydrogen
cyanide and benzaldehyde from Laetrile thus exerting its
antitumor effect (Krebs, 1970).

The cyanide released in

somatic cells of the body where low concentrations of betaglucuronidase are normally found is detoxified by large
quantities of the enzyme rhodanese, so no damage to normal
tissues would be expected to occur.

The tumor cell

according to Krebs is almost totally devoid of this enzyme
so it does not detoxify the hydrogen cyanide at the tumor
site.

Thus, Laetrile can exert its selective anti-

neoplastic activity on cancer cells (Krebs, 1970).

Krebs

additionally indicates that the benzaldehyde released during
hydrolysis of Laetrile in the presence of oxygen, is
immediately oxidized to benzoic acid which is non-toxic.
Because of Otto Warburg's (1966) demonstration of the
suboxidative activity of cancer cells, which uses more
fermentative metabolism than respiratory metabolism, Krebs
felt that this reduced aerobic metabolism in cancer cells
would slow down the oxidation of benzaldehyde to benzoic
acid.

Krebs proposed the benzaldehyde itself was a powerful

cytotoxin to neoplastic cells.

He proposed that a

synergistic effect between the cyanide and benzaldehyde
contributes to the poisoning of the cancer cells (Krebs,
1970).
Today amygdalin, as well as other natural

13

nitrilosides, are widely used in cancer therapy.

However,

amygdalin has been shown to be hydrolyzed by the enzyme
beta-glucosidase.

Research by Haisman and Knight (1967)

has confirmed the degradation of amygdalin in the presence
of a beta-glucosidase preparation.
in 3 steps.

The breakdown occurs

First the B-(1-6') bond of the gentiobiose

portion (2 glucose molecules) of amygdalin was split to
yield D(-)mandelonitrile-B-glucoside (prunasin) and glucose.
Second, the prunasin is hydrolyzed to (+)mandelonitirle
and glucose.

Third, the (+)mandelonitrile is broken down

to benzaldehyde and hydrocyanic acid (see firgure 3).
Because amygdalin had become the commonly used
natural nitriloside, Krebs (1967) tried to clarify the
confusion that often exists between the 2 hydrolyzing
enzymes (beta-glucuronidase and beta-glucosidase) of these
nitrilosides.
Both enzymes are described generally as betaglycosidases. Synthetic glucuronosidic nitrilosides
(Laetrile) have been synthesized to exploit the betaglucuronidase system in the same manner in which the
natural nitrilosides are used against the betaglucosidase system at the malignant lesion. In
comparative studies it has been found that both the
natural and synthetic nitrilosides are active against
their respective enzyme systems.
Halstead (1977) and Greenberg (1975) both made
reference to Kreb's proposed alteration to his old "cyanide
theory" when amygdalin is ingested.

According to Krebs

14

1

AMYGDALIN

Ho
2

(beta-glucosidase)

MANDELONITRII.E-GLUCOSIDE + GUJCOSE
{PRUNASJN)
~0.

{beta-glucosidase)

1

MANDELONITRIIE + GIDCOSE

(hydroxynitrilase)

HCN + BENZAI.JJEHYDE

Figure 3

DEGRADATION OF AMYGDALIN
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. amygdalin is hydrolyzed to mandelonitrile and it goes to
the liver where it is changed to Mandelonitrile-glucuronide
(Laetrile).

Then, once in this form the enzyme beta-

glucuronidase is able to hydrolyze it, releasing the
hydrogen cyanide when the glucuronide reaches the tumor
site.
Halstead (1977) states that Kreb's altered "cyanide
theory" is theoretically possible and that the prunasin
glucoside can be converted to Laetrile glucuronide but
it requires a 2 step-oxidative process not yet
experimentally demonstrated.

There has been work done

to show that glucuronide formation occurs in the liver
and to a lesser extent in the intestines and kidneys (White,
Handler and Smith, 1973).

The required beta-glucuronidase

required to convert the Laetrile glucuronide into hydrogen
cyanide and benzaldehyde has been demonstrated to be present
in cancerous tissue of the breast, uterus, stomach,
mesentary, abdominal wall and esophagus at concentrations
between 100-3600 times greater than in non-cancerous tissue
(Fishman and Anlyan, 1947).
BETA-GLUCURONIDASE
Beta-glucuronidase (B-D-glucuronide gluronohydrolase
EC 3.2.1.31) is a hydrolytic enzyme.

It is located ·in

the lysosome bodies of cells and it is widespread in animal

16
tissues.

It plays a role in the catabolism of

mucopolysacharides (the carbohydrate-protein that forms
ground substance) (Levvy and Marsh, 1960); it is also
associated with an increase in cell proliferation (Kerr,
campbell and Levvy, 1949) and tumor metabolism (Fishman,
Baker and Borges, 1959).
BETA-GLUCOSIDASE
Beta-glucosidase (B-d-glucoside-glucohydrolase
EC 3.2.1.21) is also a hydrolytic enzyme.
in varying amounts in animal tissue.

It is found

A beta-glucosidase

study on tumor and non-tumor bearing mice (Manner,
Michaelsen and DiSanti, 1978) indicated that there was
definitely a much higher concentration of beta-glucosidase
in the mammary tumor and the liver of tumor and non-tumor
bearing mice than in the brain and muscle tissue of both
tumor and non-tumor bearing mice.

It specifically

hyrdolyzes the beta-D-glucoside linkage (Greenberg, 1975).
RHODANESE
Rhodanese (thiosulfate:

cyanide sulfurtransferase

EC 2.8.1.1) is a mitochondrial enzyme which catalyzes the
formation of thiocyanate from thiosulfate and cyanide.
The enzyme has the ability to neutralize hydrogen cyanide
(Osuntokun, 1970; Montgomery, 1969 and Oke, 1969).

There

are 2 major pathways for this process to take place as

p
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seen in figure 4 (Montgomery, 1969) (Oke, 1969).
Thiosulfate in the body combines with the hydrogen cyanide
and catalyzed by rhodanese to form thiocyanate and sulphite.
This thiocyanate is excreted in the urine.

Manhardt (1978)

found that as increasing dosages of amygdalin beginning
at 500 mg/kg and going as high as 5,000 mg/kg when injected
intramuscularly into mice did increase the thiocyanate
content in the urine.

In the second pathway cyanogen reacts

with 3-mercaptopyruvate aided by another sulfurtransferase
to yield thiocyanate plus pyruvate.

There is also some

evidence that hydrocobalamin (vitamin B-12) may play a
role in cyanide detoxification, for it is able to take
up cyanide as cyanocobalamin.

It has been shown that mice

can be protected from cyanide poisoning with the
administration of hydroxycobalamin (Mushett, et al 1952).
Urinary thiocyanate excretion was found to be increased
not only by the ingestion of cyanide but also by a vitamin
B-12 deficiency (Montgomery, 1969).

Compared to the liver,

spleen and kidney cancer cells were found to have a lower
concentration of rhodanese (Rosenthal, 1948; Westley, 1973).
NATURE OF CANCER
The mechanisms of cancer cells growth have been
proposed by several scientists.

Much of the early work

is accredited to Otto Warburg, Nobel Prize winner in
Medicine in 1931 for his discovery of the oxygen

p
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3-MERCAPTOPYRUVATE

(sulfur transferase) 2-

( sul..f'ur transf'erase)
SC"r + PYROVATE

)

1

s2 o3 +

PYRUVATE

CN""

(rhodanese)

so2 - +
3

~igure

4

CN DETOXIFICATION BY RHODANESE

SCN

·
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transferring enzyme of cell respiration and voted a second
Nobel Prize in 1944 for his discovery of the active groups
of the hydrogen transferring enzymes.

He has claimed to

know the cause and prevention of cancer.

Warburg (1966)

summarized it by saying,
the prime cause of cancer is the replacement of the
respiration of oxygen in the normal body cells by a
fermentation of sugar. All the normal body cells meet
their energy needs by respiration of oxygen, whereas
cancer cells meet their energy needs in a great part
by fermentation.
Warburg (1966) supported his theory by showing
that when there was 35% inhibition of oxygen repiration
this brought about the transformation of embryonic cells
into tumor cells.

He also preferred to designate tumor

cells as "partial anaerobes" rather than "facultative
anaerobes" because a body cell is tranformed into a tumor
cell if only a part of the respiration is replaced by
fermentation.

Warburg attempted to explain the

thermodynamics of the reduced respiration on cancer
induction on the basis of dedifferentiation.

He felt that

during cancer development, when oxygen respiration falls,
the highly differentiated cells are transformed to
fermenting anaerobes which have lost all their body
functions and retain only their useless property of growth;
thus they have dedifferentiated.

Dedifferentiation provides

no work, just a true equilibrium state.

He explains this

20

difference between differentiation and dedifferentiation
energy.with chemistry rather than physics.

Both respiration

energy and fermentation energy do their work through
phosphate energy but the methods of phosphorylation are

•

different.

He sees only oxidative phosphorylation as

allowing differentiation whereas the fermentative
phosphorylation is not able to do so.

Only through the

more complex pathways of respiration is the needed amount
of energy for the differentiation of body cells attained.
He believes a tumor by itself can never succeed in
redifferentiating its dedifferentiated cells during the
short duration of a human life.
~nether

description for cancer growth has been

given the term "aerobic glycolysis" (Albert L. Lehninger,
1975}.

In it there exists an irregularity in the

integration of glycolysis and the tricarboxylic acid cycle
(respiration}.

The result is that despite a similar oxygen

consumption rate of cancer cells in relation to normal
cells, cancer cells tend to utilize 5-10 times more glucose
and convert most of it into lactic acid even though they
have a nearly normal rate of respiration.
aerobic lactate production.

This is called

This process normally occurs

in a few tissues such as erythrocytes, skeletal and heart
muscles when under heavy stress, and in the retina.

The

end result of this aerobic glycolysis which should normally

,
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be anaeorbic is that in addition to the generation of ATP
from respiration and oxidative phosphorylation there is
also a large accumulation of ATP from glycolysis due to
its increased rate.

One of the most important effects

on the body from this metabolic imbalance is the cancer
cells utilization of large amounts of blood glucose with
the release of large amounts of lactate into the blood
from glycolysis.

This lactate is then taken to the liver

where reconversion to glucose occurs by the process of
gluconeogenesis.

The energy balance from the cancer cells

metabolism thus is one of a disadvantage to the host.
The formation of one molecule of glucose from lactate
requires the input of 6 molecules of ATP whereas the cancer
cell obtains only 2 molecules of ATP per molecule of glucose
converted to lactate in glycolysis.

Large masses of cancer

cells can be quite a metabolic drain on the host, and can
be best described as metabolic parasites.
CYANIDE VS. CANCER
There are theories proposed which attempt to
directly link the function of amygdalin to the destruction
of cancer cells.

One theory is that by Mark McCarty (1975).

He describes amygdalin as possessing the capability of
producing a serum cyanide which could cause selective
toxicity to cancer cells without injury to the host.

This

mechanism involves the acidification of cancer tissue and
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the decrease of glucose available to the tumor regions
with poor links to the circulatory system.

Cyanide

activated acidification is suppose to activate the immune
system so it helps slow down, stop or even reverse tumor
growth.

McCarty's explanation helps explain why tumor

experiments performed in test tubes would not be selectively
sensitive to cyanide while tumors in vivo do show
sensitivity due to the presence of an immune system.
Brewer and Passwater (1976) have explained how,
through the presence of hydrogen cyanide and adequate
potassium levels, the cancer process within cells may occur.
As cancer causing agents (carcinogens) attach to cell
membranes, they eliminate or decrease the transport of
oxygen across the membranes.

This causes the fermentation

of glucose to lactic acid and, as a result, a drop in the
hydrogen ion concentration from 7.35 to 6.

Lysosomal

enzymes are released within the cell as a consequence of
the foregoing.

The reaction of the lactic acid and

lysosomal enzymes with the cells DNA, destroy the normal
DNA-RNA processes and regulatory mechanisms of the cell.
Thus, one means of dealing with the abnormal r.ellular
processes of cancer may be by first finding a method of
raising the pH level to 9.

A theoretical method of doing

this is by feeding the host a suitable nitrile (amygdalin)
which will hydrolyze in an acid medium to release hydrogen
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cyanide within that cell followed by the administration
of cesium or rubidium salts which along with potassium
constitute the cell membrance transportation carriers of
oxygen.

The hydrogen cyanide at the cell membrane makes

it very pervius to potassium, cesium and rubidium ions.
The concentration of the latter within the cancer cells
where hydrogen cyanide is found should raise the pH level
to 9.

As a result of this, cancerous activity should

decrease allowing the toxic enzymes in the inner layers
of cells in the tumor to bring about the death of the cancer
cells when their proliferation has stopped.

Here the

amygdalin's hydrogen cyanide is not directly involved in
attacking the cancer cells themselves but rather it serves
as a catalyst for the chemical reactions that slow down
cancer growth.
Research reported by Lea, Koch and Morris (1975}
have shown that sodium cyanate at a dose level of 125 or
250 mg/kg i.p. causes an inhibition of the incorporation
of labeled amino acids into cytoplasmic and nuclear proteins
of various heptomas (tumor of the liver}.

However, in

the livers of rats bearing these tumors there was no
inhibitory effect on the incorporation of labeled amino
acids into protein.

These studies indicate that a greater

than 85% inhibition of amino acid incorporation could be
brought about with sodium cyanate in hepatoma 5123C,
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hepatoma 9618Azand the MK3 kidney tumor whereas there was
little or no effect on the kidney, liver, brain, skeletal
muscle, intestinal mucosa and regenerating liver (after
partial hepatectomy) of those animals bearing tumors.
Another hypothesis has been proposed by Brekhman
and Dardymov (1969).

It deals with adaptogens which they

say increase the nonspecific resistance of the host.
"Adaptogens are substances that are able to bring on a
normalizing effect within the host's general resistance
to disease".

They found that certain plant glycosides

have the ability to increase the overall immune mechanism
of the body to such degenerative diseases as cancer and
atherosclerosis.

They believe the adaptogens may function

by stimulating the production of immune bodies and involve
the biosynthesis of protein and influence nucleic acid
metabolism.
Oke (1969) indicates that cyanide in the body has
an affinity for metal ions such as copper.

It is able

to combine with haemoglobin to form cyanohaemoglobin which
is not an oxygen carrier.

Also there is the reversible

combination with the copper of the cytochrome oxidase which
thereby inhibits its function as an oxidative enzyme in
electron transfer resulting in a condition known as
histotoxic anoxin.

,
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TOXICITY STUDIES
Different amounts of foods, poisons and drugs are
required in order for some type of effect to take place.
The correct dose of each is what differentiates a poison
from a medicinal dose.

Amygdalin is no different and its

toxic effects are partially governed by dose and method
of route of administration (Halstead, 1977).
There has been discrepancy in the results obtained
from the toxicity studies of amygdalin.

Beginning with

the raw almond kernel itself, Trube-Becker (1965) estimated
that 50-70 nuts would have to be eaten to provide a lethal
dose to adults and as few as 7-10 almonds for a child.
He indicated that these numbers may vary since the amygdalin
content diminishes during prolonged periods of storage,
and simultaneous ingestion of sugar decreases their toxic
effect.

Auld (1912-1913) has suggested that beta-

glucosidase is inactive at the pH of human saliva or of
gastric juice and was also inactiviated by the presence
of cellulose or glucose.

The latter could explain Trube-

Becker•s finding of decreased toxicity of ingested amygdalin
with sugar.

Reports confirming these oral toxicity findings

have been found when there was accidental ingestion of
too many kernels (McTaggarts, 1936).
Auld (1912-1913) has shown guinea pigs fed amygdalin
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in amounts up to twelve lethal doses of hydrogen cyanide
per day showed no ill effect.

Another study reported by

the Cancer Commission of the California Medical Association
(1953) showed that amygdalin that was given by stomach

tube to mice was found safe at doses below 300 mg/kg but
once 400 mg/kg and higher doses were administered death
occurred in a matter of minutes to one hour.

Dr. Navarro,

(1959) who uses amygdalin therapy on cancer patients,

suggests that amygdalin is hydrolyzed by the hydrochloric
acid in the stomach and should never be given by mouth
(Lewis, 1977).

Other routes of administration have proven
~

to be far less toxic.

In animals given intravenous doses

in excess of 100 times the intravenous dose given to humans,
amygdalin proved non-toxic.

Conversely, the oral toxicity

of the compound was found to be 39 to 44 times greater
than the intramuscular route (Halstead, 1977).
In human cancer therapy, amygdalin has been
administered in dosages up to 70 gms in adult humans by
combined oral and parenteral routes without ill-effects
(Rubin, 1977).

Lewis (1977), however disagrees with Rubin's

findings, and he indicates that 3 grams of amygdalin
contains 180 mg of cyanide and that 200 mg of cyanide are
toxic to humans.
Hill et al (1976) found that mice receiving
intraperitoneal (i.p.) injections of amygdalin in dosages

,.
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ranging from 50-500 mg/kg for 4 days showed no toxic effects
but higher doses of 2000 mg/kg for 4 days caused a 5% death
rate.

In a study by Browne (1974), intravenous injections

of 500·mg of amygdalin on alternate days for a total of
6 injections caused remission of thyroid carcinoma in dogs.
Campbell (1974) gave no indication of toxic results when
he injected albino mice with 1000 rng/kg i.p. injections
for 10 days.

In

ou~

labcratory toxicity studies with

amygdalin administered to JaxC57BL/KsJ mice and dosages
ranging from 1000-2500 mg/kg for 15 days intramuscularly,
proved to be non-toxic to the adult mice (Manner, DiSanti
and Michalsen, 1977).

Other experiments have confirmed

such non-toxicity of amygdalin administered at high dosages
and Burk (1971) found that unhydrolyzed amygdalin is nontoxic to all animals studied.

He found that dosages up

to 5-10 gr/kg by various routes of administration were
non-toxic, and he also found that concentrations of either
cyanide alone or benzaldehyde alone were far less effective
in killing or metabolically disturbing

Erlich ascite

cells in vitro than equivalent concentrations of amygdalin
plus a small amount of beta-glucosidase.
The amygdalin used is normally laevo-rotary.

When

the racemic form, designated as Amygdalin MF (NSC 1578)
has been used, different results have been obtained.

In

a study by Wodinsky and Swiniarski (1975), Amygdalin MF
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used at dose levels as high as 800 mg/kg administered i.p.
to mice for 9 days showed no toxic effects.

Early deaths

were noted, however, when 10 mg/kg of beta-glucosidase
was injected i.p. one-half hour prior to 100 mg/kg of
Amygdalin MF.

Beta-glucosidase was found to be non-toxic

by itself at doses as high as 10 mg/kg.

Results from a

similar study by Laster and Schabel (1975) using Amygdalin
MF, found that when amygdalin MF was administered without
beta-glucosidase 10% deaths were produced at a dose of
500 mg/kg, 30% deaths occurred at 335 mg/kg and no deaths
occurred at 220 mg/kg for 9 days.

When beta-glucosidase

at 10 mg/kg dose was administered simultaneously with
Amygdalin MF the highest level of Amygdalin MF that they
found that could be given without exceeding the LDlO in
normal mice was 53 mg/kg dose.
An in vitro study by Levi et al (1965) was based
upon incubation of surviving tumor tissue slices or cell
suspensions in Warburg Manometric vessels in the presence
of radioactive tracers.

During incubation tumor respiration

and glycolysis was measured.

After incubation,

tissu~

was assayed for the incorporation of the tracers.

Two

types of amygdalin were used in this experiment (United
States and Canadian brands).

When these compounds were

analyzed both contained amygdalin but the Canadian type
also contained .5% phenol whereas the

u.s.

brand contained
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sucrose and isopropylammonium iodide.

The results of this

study demonstrated that dosages of 4mM of both amygdalins
had no significant effect on respiration of the cancer
cells; however NaCN at much lower concentrations (.lmM)
almost completely inhibited respiration of the human
adenocarcinoma.

NaCN also changed aerobic glycolysis of

the tumor cells to anaerobic pathways.

The effects of

amygdalin on protein, RNA and DNA synthesis determined
by labeled amino acids, showed that except for inhibition
of DNA synthesis by amygdalin (Can.), there were no other
effects.

NaCN, aerobically in the absence of glucose,

completely inhibited all three syntheses in the tumor cells.
Such inhibition was not seen, aerobically and anaerobically,
when NaCN was added to vessels containing glucose.
Apparently the NaCN inhibitory effect on respiration was
overcome by the increase in aeorbic glycolysis when glucose
was present.
Krantz et al (1936) found that i.p. injections
of potassium cyanide showed no growth inhibition or tendency
to regress the Walker rat sarcoma 319.

Perry (1935) showed

that prolonged inhalation of cyanide arrested body growth
in young rats and retarded the growth of Jensen sarcoma
implants.

Both

r~gressing

and growing tumors in treated

animals had little capacity for transplantation.

The range

of the effective dose was limited and too close to the
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lethal dose to be practical.
TROPHOBLASTIC THEORY
Ernst T. Krebs, Jr. owes much of his background
for the development of his Laetrile~ to the Scottish
embryologist by the name of John Beard (1858-1924).

Beard

published his findings in the British Jounral Lancet under
the title of "Embryological Aspects and Etiology of Cancer"
(1902).

Later on in 1911 he published a book entitled

"The Enzymes Treatment of Cancer and Its Scientific Basis".
Beard's study was based on a trophoblast cell.

This cell,

first identified in 1857 and then named in 1876, was found
to play a specific role in pregnancy.

This trophoblast,

regarded by some as an extraembryonic ectoderm of the
embryo, spreads and multiplies rapidly appearing to eat
its way into the uterus wall preparing a place where the
embryo can attach itself for maternal protection and
nourishment.

For these and other characteristics, John

Beard, Krebs, Sr. and Jr. and H. Beard believed that
trophoblast cells and cancer cells were identical.

A new

title was later given for John Beard's study, "The Unitarian
or Trophoblastic Thesis of Cancer" (Krebs, Jr., Krebs,
Sr. and H. Beard, 1950).
H. Beard (1958) described John Beard's concept
of trophoblast and cancer cells development.

It begins
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with the union of the egg and sperm to form the zygote,
which is the origin of asexual trophoblast and the germinal
tract along which the primitive germ cell develops.

The

trophoblast undergoes mitosis at once while the primitive
germ cell does not begin to divide until later.

There

was first to be the development of 35 trophoblast cells
before the primitive germ cell begins to divide.

This

he felt accounted for the rapid development of the
trophoblastic tissue (the asexual generation having no
sex organs) in early pregnancy.

Later, the primitive germ

cells would divide by 7 mitosises, giving a potential female
embryo an additional division or 256 primary daughter germ
cells.

One of these germ cells will go on to develop into

the embryo (the sexual generation possessing sex organs)
and the rest would migrate into the embryo, most reaching
their destiny in the gonads but 20% never arriving there
but landing in ectopic sites (abnormal positions) in the
body which later on could develop into benign or malignant
tumors.

What determines the type of tumor is pure chance.

The ectopic germ cell, having a embryonic destiny begins
to develop asexually becoming an embyrona, asexual twin
or benign tumor.

If the embryonic stage is skipped then

the ectopic germ cell is forced by an excess of the female
sex hormones to start the process of meiosis.

The resulting

haploid gametogenous cell either dies or it is changed
into the ectopic trophoblast cell which forms the malignant
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tumor (Beard, 1958).
What had puzzled John Beard is why the trophoblast
eventually would be destroyed in normal pregnancy but cancer
cells were not.

The answer he found was that on the 56th

day of pregnancy the cellular trophoblast begins to
deteriorate and it is on this same day that the fetal
pancreas begins its secretory function.

The pancreas is

the site of the inactivated (zymogens) pancreatic enzymes.
Upon activation the enzymes get into the bloodstream and
when they accumulate in sufficient quantities at the
trophoblast, they eat away and digest these cells (Griffin,
1974).
BOVING'S BIOLOGY OF THE TROPHOBLAST
Bent Boving (1960) explained his ideas on the
biology of the trophoblast.

He indicates that the

trophoblast structure is not solely restricted to mammals,
but that eggs of lower vertebrates show trophoblast-like
behavior mostly of a nutritive and anchoring function.
The nutritive property is primitive in the trophoblast
whereas its invasive property found in mammals (but not
all) is not a general property; it is more a comparatively
late elaboration with many variations in anatomical detail.
He feels the invasiveness is not so much a basic
characteristic of an undifferentiated tissue as it is just
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one of the many specializations of structure and function
that a particular undifferentiated tissue may acquire and
later on lose.

The idea that the invasive property of

the trophoblast is turned on then off is too simple.

Boving

(1960) has seen evidence of a human conceptus 11 days old
that had passed through epithelium 5 days earlier and
presumably injured it so that now it was in direct contact
with the trophoblast.

The trophoblast was separating the

conceptus from the blood supply and the epithelium was
not only surviving but healed the breach.

Adjacent

trophoblast tissue was still growing and could be seen
engulfing a maternal vessel.

He speaks only briefly about

the similarities between trophoblasts and cancer cells.
He feels the proof thus far available has not satisfied
what he calls the "logical requirements for avoiding a
mistaken conclusion".

He will continue to feel this way

as long as clinicians and pathologists can distinguish
pregnancy from cancer and as long as cancer and pregnancy
can coexist in one patient yet progress to different fates.
Boving further suggests what he believes is the
mechanism of trophoblastic invasion after anatomical
analysis of a rabbit trophoblast.

The abembryonic rabbit

trophoblast invasion at the antimesometrial uterine
epithelium appears to be brought about locally by contact
and by what Boving described as a trophoblast knob

\
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(aggregates of trophoblastic syncytium forming slight
projections and a pointed shape) and uterine epithelium
with a vessel below.

The invasion may be brought about

at this site by a chemical produced in the blastocyst and
transferred to maternal circulation.

Boving feels it is

not locally promoted by products secreted or stored in
the endometrium.
Boving (1960) condensed the invasive mechanism
of an abembryonic rabbit trophoblast into the following
hypothesis.
One or two days before implantation, blastocyst
metabolism increases so greatly that the previously
adequate respiratory mechansisms become insufficient.
Glycolysis relieves some of the energy needs, but
metabolic wastes are produced faster than ever, and
some accumulates as bicarbonate thanks to a buffer
system. As the time of implantation nears, progesterone
augments endometrial carbonic anyhydrase and there
by indirectly accelerates the removal of the accumulated
bicarbonate by speeding carbon dioxide "blow off" from
carbonic acid within the epithelial cell. As the carbon
dioxide is carried off by maternal circulation at the
base of the cell, alkaline products are left behind.
The consequent local pH rise causes disaggregation
of· epithelial cells in which it occurs, while the
adjacent trophoblast, being synctial, remains intact
and thus replaces the epithelim.
Boving' (1960) warns that this hypothesis cannot be
generalized for all invasions because anatomy of
placentation varies in mammals, endometrial carbonic
anyhydrases occurrences are variable and most invasive
tumors are cellular, not synctial.

Boving therefore makes
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no attempt to pinpoint the specific relationship of cancer
cells and trophoblasts but only to bring about questions
of their relatedness.

He feels that the high metabolic

rates, glycolytic abilities and respiration insufficencies
are probably a characteristic of both cancer and rabbit
blastocyst.

If this metabolism plus compensatory pH

regulation by an alkali reserve are responsible for rabbit
trophoblast invasion, it is possible, he believes, that
these similar chemical mechanisms could work on cancer
cells.

He feels that the difference in the two could be

that respiratory insufficiency of cancer cells is permanent,
intrinsic and not subject to external control, whereas
the trophoblast respiratory inadequacy is temporary,
extrinsiic, and believed to be relieved by the trophoblast's
normal physiological objective that of the maternal
circulation.
CANCER AND EMBRYONIC CELLS.
Trophoblast and cancer cells share in the production
of chorionic gonadotropin hormones (CGH).

Evidence of

CGH in urine of cancer victims goes back many years (Krebs,
1946).

In 1971, Li Reports that the syncytotrophoblastic

cells are a source of chorionic gonadotropin secretion •
.A small choriocarcinoma was found capable of secreting
10 times or more the maximum amount of chorionic
gonadotropin produced during a normal single pregnancy.
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The amount present indicates only the presence of tumor
and does not reflect its total mass but does correlate
with the observable changes in the tumor growth (Li, 1971).
Teratomas are congential tumors containing embryonic
elements of all 3 primary germ layers.

The most widely

accepted theory as to their origins is that they are derived
from diploid germ cells (Stevens, 1964, 1967).
such as

teratom~s·being

Evidence

more common in gonads than any

other site is one of the several facts about them that
confirms this theory.

Li (1971) defines the trophoblastic

diseases as chorionic tumors that may originate either
from the placenta or from the germinal cells of the gonads
of both sexes.
Micaletti (1977) demonstrated that amygdalin had
a definite effect on undifferentiated embryonic-like
blastema cells of regenerating limbs on salamanders.

After·

the right forelimb of salamanders were amputated the animals
were injected daily for 15 days with 2000 mg/kg of
amygdalin.

There was no difference found in the thickness

of the regenerated epidermis (non-embryonic) in the control
and treated groups.

However, the pluripotential fibroblasts

were significantly inhibited in the treated group.

Blastema

cells of the experimental group developed to a mean length
of only half the measurement that was found in the control
group.
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TERATOLOGY
Teratological studies examine the possible adverse
effects of the enviro9ment on developing systems of germ
cells, embryos, fetuses and immature postnatal individuals.
This environment of the embryo or fetus is everything
outside its skin such as the surrounding membranes, oxygen,
nutrients or foreign chemicals.
The following information is reported by Wilson
(1973).

The three main aspects that must be considered

in the teratological study are causes, mechanisms and
manifestations.

Causes are the action by an agent from

the environment on germ cells, embryos or fetuses.

The

agents may be radiation, chemicals, dietary imbalance,
infection, hypoxia, temperature extremes, metabolic or
endocrine imbalance, physical trauma and placental failure.
One of these or a combination of them may produce the
mechanism which occurs within the germ cells, embryos or
fetuses producing mutations, chromosomal nondisjunction,
mitotic interference, altered nucleic acid integrity or
function, lack of precursors or substrates, altered energy
sources, changed membrane characteristics, fluid-osmoylte
imbalance and enzyme inhibition.

These may lead to

manifestations of pathogenesis initiated by one or more
of the following:

cell death where there are too few cells
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to carry out morphogenesis or functional maturation; failed
cell interaction where there is insufficent growth or
activity of inductor tissue or lack of competence of induced
tissue; reduced biosynthesis caused by inhibition of nucleic
acid, protein or mucopolysaccharide synthesis; impeded
morphogenetic movement where obstruction of cell migration
or interference with invagination; tissue disruption caused
by pressure, trauma or vascular stasis and altered
differentiation schedule where the differentiation and/or
growth are slowed down.

The final result of one or more

of these is intrauterine death, malformation, growth
retardaton or functional deficit.

There is a degree of

vulnerability to these induced developmental deviations
but experimental studies in animals have clearly shown
that the greater danger is associated with a relatively
short period of critical embryogenesis between germ layer
differentiation (gastrulation) and completion of major
organ formation.

It is felt that the period beginning

from fertilization through cleavage, blastocyst and early
germ layer stages is the least susceptible to teratogenesis
but appreciable lethality may occur.

This is followed

by the period of highest susceptibility to teratogenesis,
that of differentiation and early organogenesis.
Significant embryo death can occur at this time if doses
are high enough.

As organogenesis advances in the later

part of the embryonic period the occurrence of teratogenesis
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and death decline greatly.

There must be a significant

elevation in dose if teratogenicity or lethality is to
occur at all.

Organogenesis is when the major processes

within the embryo are differentiation, mobilization and
organization of cell and tissue groups into organs.
Interference at this time by teratogens causes gross
structural defects usually malformations.

Histogenesis

is characterized by successive cellular and tissue
specialization which convert the primordial organs into
definitive one.

At this time functional maturation aiso

begins, and both of these now continue throughout the fetal
period progressing toward the size and proportions typical
of the newborn.

Interference during this period is expected

to result in growth retardation and functional disturbances.
Experimentally, these observations

h~ve

been demonstrated

with a variety of agents, such as irradiation (Wilson,
1954), maternal vitamin deficiencies (Warkany, 1954), drugs
such as cortisone (Franser and Fainstat, 1951), and vitamin
excess (Cohlan, 1954).

They have all shown to produce

their most severe teratogenic effects at specific times
during gestation as well as specific types of developmental
disturbances.

That gestational period that has been found

to have the maximum frequency of response to the teratogen
is referred to as the critical period.
DiPaolo (1969) indicates four requirements that
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must be considered for experimental teratogenic studies;
the method of administration of a specific treatment, the
dose, the use of the genetically susceptible animal, and
knowledge of when the embryos are in susceptible stage
of development (DiPaolo, 1969).

The dosages used in any

teratogenic study are dependent upon potency and duration
of the treatment.

There seems to be ample experimental

support for the belief that teratogenic and embryo-lethal
substances can be shown to have a threshold below which
adverse effects are not found (Wilson, 1973).

Karnofsky

(1965) has found that most if not all drugs and chemicals
can be shown to produce some type of embryo toxicity if
applied in sufficent dosage during an appropriate time
in embryogenesis in one or more species of animals.

The

beginning dosage should begin at or above the highest
anticipated therapeutic level and should increase until
the threshold of embryo toxicity in appropriate test animals
is found (Wilson, 1973).

There are several acceptable

methods of administration of the agent and each has their
own advantages and disadvantages.

The route chosen is

usually the one that would be used clinically (Wilson;
1973).
The choice of test animals to be used in a
teratogenic study is still debatable.

It is generally

accepted that no animal test will provide complete assurance

41
in the prediction of human teratologic risk.

The ideal

test animal should have the -following characteristics:
absorb, metabolize and eliminate the tested agent in the
same way as humans do, transmit this agent and its
metabolite across the placenta at the same rate as in humans
and have embyros and fetuses that have developmental
schedules and metabolic pathways similar to humans.

There

is no presently used species, even the simian primates,
that meet these requirements, in all respects (Wilson,
1973).
USE OF THE MOUSE
The small size of mice does make it difficult to
examine fetuses for defects.

Their sometimes erratic

breeding behavior and the high and occasionally variable
rates of background malformation and intrauterine death
in several inbread species are disadvantages in using the
mouse in teratological studies (Wilson, 1973).
their advantages include low

However

cost, small size (minimizing

care and space) and the large amount of information known
on their genetics, their physiology as well as their
embryologic development (Dagg, 1963).

The genetics of

the mouse is better known than that of any other mammalian
species (Grunberg, 1952, 1963).

It has been shown that

frequencies of malformation development due to a teratogen
will vary among different strains of inbred mice.

Inbred
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strains (mating brothers and sisters for many years) develop

homozygous stock that makes for good genetic uniformity
but they may become resistant to teratogenesis by some
agents (Wilson, 1973).

Conversely, mice are known to

respond readily to substances that have limited
teratogenicity in other animals, for example, cortisone
and the herbicide 2,4,5-T (wilson, 1973) earning them a
justified reputation for unusual sensitivity.
PLACENTAL DEFENSES
Wilson (1973) feels that chemical agents used in
teratology probably always are able to reach germ cells,
embryos and fetuses in some fraction of their concentration.
The determining factor for abnormal development would depend
on whether a critical dosage reaches or accumulates in
the developing organism.

Catabolic breakdown, excretion,

protein binding and tissue storage normally reduce the
concentration of foreign chemicals in the maternal
bloodstream decreasing the amount reaching the conceptus.
In a study by Juhasz (1976) on the passage of LAS (linear
.alkylbenzene sulfonate) across the teleost and mouse
placenta, she found LAS to reach the embryo.

However,

through the use of liquid scintillation spectrophotometry
more radioactive LAS was found in the zebra fish than the
fat head minnow.

An explanation offered was that the fat

head minnow has a longer development time and maybe a slower
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metabolism.

Data indicated that the LAS also passed into

the mouse embryo after intraperitoneal injections.
Villee (1967) is of the opinion that the placenta
should not be regarded as a barrier in the sense of being
impervious because it probably does not absolutely exclude
any chemical agent.

However, the placenta is able to offer

some chemical agent concentration reduction for the embryo
or fetus.

Rodents all possess a specialized placental

structure called inverted yolksac placentae.

Embryos of

these species may be dependent on this atypical structure
for nourishment during the critical first few days of
organogenesis.

It has been shown to be structurally and

functionally different from the typical chorioallantoic
placenta that is found in other mammals, (Everett, 1935;
Padykula et al, 1966; Becket all, 1967 and Brent, 1971).
Experiments using rodents have shown indications of embryo
toxic effects at lower doses than those seen in monkeys
(Wilson, 1971).

Thalidomide was one of the shocking

exceptions to the rule.

Wilson (1972) reviewing

teratological studies using non-human primates saw that
primates showed little or no teratogenic effect to many
chemical agents that are highly teratogenic to rats, mice
and rabbits.
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TERATOGENIC STUDIES OF AMYDGALIN
Kreb's "cyanide theory" regarding amygdalin's
specificity for cancer cells and the similarities found
between trophoblast and cancer cells, warrant an
investigation into the effects that amygdalin may have
on implantation of the mammalian embryo and the general
toxic effects it may have on the fetuses.

Only one

reference to such studies has been mentioned in passing
in an editorial article on Laetrile in the "Western Journal
of Medicine" (Lewis, 1977).

Lewis makes reference to a

teratological study of Laetrile by the McNaughton Foundation
in their 1970 IND (investigational new drug application).
The investigation was performed on pregnant rats fed 5
or 25 mg/kg body weight per day of amygdalin.

The control

group had one fetus with a kidney abnormality and the 25
mg group had 2 fetuses with kidney abnormalities.

One

fetus in the 5 mg group was also found to be hydrocephalus.
However no mention was given to the total number of fetuses
examined or when and how long the animals were treated.

MATERIALS AND METHODS
GENERAL PROCEDURES
Jax C57BL/KsJ 6 week old virgin mice, Mus musculus,
were obtained from Jackson Laboratories, Bar Harbor, Maine.
The mice were at least 10 weeks old before being used in
the experiments.

Prior to experimentation, the mice were

housed 4-6 in a cage (plastic shoe-box type) containing
inert bedding (Sanicel).

The mice were fed Purina Mouse

Chow and given tap water ad libitum.

Water bottles were

checked daily and cages changed routinely.

The room in

which the mice were kept before and during experimentation
was temperature-controlled and on a 12 and 12 hour light
and dark cycle.
Breeding was initiated by exposing female mice
to male mice of the same strain in a 3-4 to 1 ratio.

The

presence of a vaginal plug was the criteria that mating
took place and this was designated as day one of her
gestational period.

Females were randomly assigned to
•
the control or treated groups at the time the plug was

detected.

Each mated female was placed separately in her

own cage and housed and cared for in the same manner as
45
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before.

Treatments began on the first day and were

i

continued everyday throughout pregnancy.
PHASE I - NATAL STUDY
The control group received .3cc of isotonic Lockes
solution injected intramuscularly into the rear thigh.
The treated group received .3cc of amygdalin in the same
manner as the control animals.

This dose of amygdalin

was based on a 30 gram mouse and was equivalent to a 500
mg/kg body weight dose.
500 mg amygdalin
1 kg body wt.
X

=

X mg amygdalin
.03 kg mouse

=

15 mg amygdalin/injection

=

.015 gm amygdalin/injection

.Ql5gm amygdalin/injection
.3cc injection volume

X =

=

X gm amygdalin
30 cc H2o
(distilled-deionized)

1.5 gm amygdalin

Thus, 1.5 gm amygdalin were dissolved in 30 cc of distilleddeionized water and .3cc was equivalent to a 500 mg/kg
dose.

Amygdalin solutions were prepared fresh daily.

This dose is 2-3 times greater than that received by
patients on amygdalin therapy.

This dose was also found

to be non-toxic to the Jax C57Bl/KsJ mouse when administered
intramuscularly (Manner, DiSanti and Michalsen, 1977).
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The amygdalin was obtained from Sigma Chemical Co., St.
Louis, Missouri.
Both groups of animals were weighed daily to
determine if the mice did become pregnant and to note any
sudden decrease in weight which may indicate embryonic
reabsorptions.

Both groups were allowed to carry their

pregnancy full term and after delivery that same day, the
newborn pups were collected and the litters weighed.
average weight for each pup was calculated.

An

Each pup was

then sexed and examined for external abnormalities.

Sex

differentiation was based on the knowledge the anus and
clitoris are roughly one-half to two thirds as far apart
as the anus and the penis in newborn mice.
were then each divided in half.

The litters

One half was stored in

vials of Bouin's Fixative (Humason, 1962) for 2 weeks and
sectioned according to Wilson (1965).
BODIN'S FIXATIVE (Humason, 1962)
Picric acid, saturated aqueous ••••••••••

75.0 ml

Formalin................................

25.0 ml

Glacial acetic acid.....................

5.0 ml

The pups were sectioned by hand with a razor blade into
1-1.5

m~

thick sections that began at the nose and continued

through most of the length of the body in this fashion.
The other half of the litter was placed in 95% ethanol,
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cleared and stained with Alizarin Red according to Gurr
(1953).

Bone staining with this technique resulted in

red-stained bones in contrast to the unstained transparent
soft surrounding tissue.
ALIZARIN RED TECHNIQUE (Gurr, 1953)
For bone staining in small vertebrates (Dawson's method)
Solutions required:
A.

Potass. hydroxide 1% acqueous

B.

Alizarin Red,

C.

1.

s .........................

Po tass. hydroxide. • • • • • • • • • • • • • • • • • • • • • •

10 gm

Distilled water •••••••••••••••••••.•••••

1 liter

Mall's solution
Glycerin ...............................•

20 ml

Distilled water ••••••••••••••••••••.••••

79 ml

Potass. hydroxide •••••••••••••••••••.•••

1 gm

Whole specimens are fixed in 95% alcohol for
at least three days.

2.

Transfer to acetone and leave several days
to dissolve out fats.

3.

0.1 gm

Wash well with 95% alcohol; then immerse
in 95% alcohol for 24 hours.
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4.

Immerse in Solution A from one to seven days,
according to size of specimen, until the bones
are clearly visible through the muscle.

5.

Transfer to Solution B until bones are stained
the desired depth of color; this takes from
one to seven days, and the solution should be
changed on the 4th day.

6.

Clear in Solution C until no more color
comes out.

7.

Pass into a mixture of equal parts of
glycerin and water, and continue through
increasing strengths of glycerin.

8.

Store in pure glycerin.
The eighteen and nineteen day old pups fixed in

Bouin's Fixative and sectioned according to Wilson (1965)
were examined for gross physical characteristics but
histological characteristics were not studied.

Pups were

examined for syndactyly, polydactyly, and adactyly,
phocomelia, exopthalamus, anopthalamia, microphthalmia,
hydrocephaly, exencephaly, cleft plate, heart chambers
division, number and position of kidneys, development of
esophagus, trachea, lungs, liverI stomach and gonads and
other digestive organs.
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The stained pups with Alizarin Red were examined
for normal development and number of ribs, cervical,
thoracic and sacral vertebrae, sternebrae as well as general
skeletal bones of the palate, arm, legs, shoulder and pelvic
areas.
PHASE II - PRENATAL STUDY
A dosage of 2000 mg/kg of amygdalin was chosen
for this study because although it was a high dose it was
still non-toxic to the adult female animal (Manner, DiSanti
and Michalsen, 1977}.

The procedure used for the experiment

with this new dose was the same as the previous study except
for 2 variations.
VARIATION I
The control group received .3cc of isotonic Lockes
solution and the treated group received .3cc of amygdalin
equivalent to 1000 mg/kg body weight into both right and
left rear thighs daily.

A concentrated mixture of amygdalin

for one single injection of .3cc at 2000 mg/kg dose could
not be obtained without the immediate occurrence of a
precipitate.

The dose of amygdalin was based on a 30 gm

mouse and was equivable to 2000 mg/kg body weight.

r
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2000 mg amygdalin
1 kg body wt.
X =

=

=

X gm amygdalin
.03 kg mouse

60 mg amygdalin/injection
·.o6 gm amygdalin/injection

.06 gm amygdalin/injection
.6cc injection volume

X

=

=

X gm amygdalin
10 cc a 2o
(distilled-deionized)

1 gm

thus, 1 gm of amygdalin was dissolved in lOcc of distilleddeionized water and .Gee was equivalent to a 2000 rng/kg
dose.

The mouse could best accomodate intramuscular

injections of .3cc into.both rear legs instead of giving
one large injection of .6cc.

Due to the small size of

this strain of mice injections exceeding the volume of
.4cc caused leakage from the site of injection.
VARIATION II
The mother mouse has been observed to eat her
offspring when they were born dead or abnormal.

Thus,

precautions against maternal cannibalism were more closely
controlled this time because the chances for abnormal
development or death to the offspring would be expected
to be greater at this higher dosage.

The female's pregnancy

was terminated after she had completed 18 full gestational
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days by over-etherization.

At this time she had received

a total of 18 injections of amygdalin each at a dose of
2000 mg/kg.

The fetuses were removed from the uterus and

recorded as living if movement was detected.

Reabsorptions

were recognized by underdeveloped embryos or yellow nodules
(metria! glands), and were recorded.

Fetuses were blotted,

litter weights were taken, and average pup weights
calculated.
Procedures for examination of the fetuses were
the same as in the previous study.

Both external and

internal development as well as skeletal formation were
examined.
RECORDS FOR PHASES I & II
Litter sizes and weights, pup average sizes and
anamolies were recorded for all groups studies.

Photographs

were taken of controls and 500 mg/kg and 2000 mg/kg
amygdalin treated animals, for both Wilson's sectioning
technique and the Alizarin Red skeletal staining.

Means

and standard deviations were calculated for pup and fetus
weights and litter sizes.

Student t-Tests were used to

determine if there were statistical difference between
the groups.
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PHASE III - POSTNATAL STUDY
There were 3 groups of treatment in this study,
a control group, a group that received 500 mg/kg dose of
amygdalin and a group that received 2000 mg/kg of amygdalin.
The procedures for mating and administering the amygdalin
were carried out in the same manner as Phases I and II.
The females were permitted to carry their pregnancy full
term.

When the females gav·e birth the injections were

stopped in all groups.

The number of offspring were counted

in every litter and returned to their mother to care for
them the next three weeks.

Daily examination of the litters

were made to remove any pups that had died and to look
for anamolies that could have been developing.

At the

end of the three week period the number of offspring were
again counted in each litter and at the same time examined
for physical or behavioral abnormalities that may be
apparent.

Student t-Tests were used to examine the data

for statistical differences.

RESULTS AND DISCUSSION
Chronic doses of amygdalin were administered over
the entire period the mouse was in gestation instead of
only 3-4 days during periods of organogenesis as suggested
by Wilson (1973).

This teratogenic study attempts to

simulate the same procedures that are employed in human
clinical use of the agent.

The reason for using these

chronic doses is that patients on amygdalin therapy must
remain on amygdalin for prolonged periods of time.

Even

after treatment appears successful or even if the cancer
has been surgically removed, maintenance doses of amygdalin
are recommended so that the total length of time of
amygdalin administration can far exceed the nine month
period of human gestation.

If any adverse effects on the

mouse fetuses would have been found in our study which
can be attributed to chronic does of amygdalin, isolation
of the particular stage of development affected by the
administered amygdalin could be later on determined with
further studies.
Freehand razor blade sectioning by Wilson's
te~hnique

is reliable for most small species of test animals

and histological serial sections are generally regarded
54
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as impractical (Wilson, 1973).

The specimen's fixation

in Boulin's is advantageous because it causes less shrinkage
of the specimen and because of its acidity it decalcifies
bony structures within a week or two greatly facilitating
the sectioning process (Wilson, 1965).
Wilson's technique for examination of the fetuses
is reliable for most physical defects (Wilson, 1965).
Control groups played a great part in determining what
was a normal condition in this teratogenic study of the
mouse.

However, since this is a less accurate method than

histological techniques, Phase III study was conducted.
Allowing the offspring to live for 3 weeks would make any
defects that may bave been overlooked become apparent with
growth of the animal.

Also functional anomalies could

be examined that many times are not investigated in
teratogenic studies because they are too time consuming.
The results (Tables I-V) from all three studies
(Natal, Prenatal and Postnatal) indicate that there is
no significant teratogenic effects on the mice offspring
whose mothers have been treated with chronic doses of
amygdalin.

Statistical analysis on the litter sizes and

average pup weights for the studies comparing controls
with groups treated at 500 mg/kg and 2000 mg/kg, showed
no significant differences.

In a study comparing controls

with a 500 mg/kg group (Table I), one death in each group

"""'' III

TABLE

r

m1ALE GESTATION PERIODS AND LI'.rl'ER SIZES

A\'ERAGE PUP \·/EIGHTS
GROUP I

-

GROUP II
CONTROL

Af1YGDALIN TREATED m1ALES

(500 mg/kg)
Female
No.
1
2
3
4

5

6
7
8 .
9
10
. 11
12
+

•

Gestation
Period
Days
19
19
20
20
20
20
19
19
19
20
19
19

Total
Litter
Size

6
8
9
6
9
5
8
5
6
8
8
10+•

Average
Pup
Weight(g)
1.25
1.47
1.34
1.30
1.28
1.21
1.31
. 1 ...39
1.32
1.18
1.35
1.26

Female
No.

1
2
3'

4
5
6
?
8
9
10
11
12

Gestation
Period
Days

Total
Litter
Size

Average
Pup
Weight(g)

19
19
19
19
19
19
19
20
19
19
19
19

6
6
6
8
6
7
7
9+
7
4
7
8

1.,30
1.29
1.41
1.30
1.33
1.28
1.34
1.22
1.27
1.49
1.38
1.28

=1

Pup born dead which is included in total litter size number.
= 1 Undeveloped embryo which is included in total litter size number.
CJ1
0')

-......

TABLE II
FEMALE GESTATION PERIODS AND LITTER SIZES
AVERAGE PUP \/EIGHTS
GROUP III

GROUP IV

Af.IYGDALIN TREATED FEHALES
( 2000 mg/kg)
Female
No.
1
. 2
3
4
5
6
7
8
9
10
11

• =1

Gestation
Period
Day-s
18
18
18
18
18
18
18
18
18
18
18

Utter
Size
5***
8
7
7
6
8
7
8
6
8
7*

CONTROL
...

Average
Pup
Weight(g)
1.05
1.17
1.27
1.12
1.10
1.01
1.36
1.20
1.14
1.12
.83

..

Female
No.
1
2

3
4
5

Gestation
Period
Day-s
18
18
18
18
18

Utter
Size

9

4•••

8
9
8

Average
Pup
Weight(g)
1.17
1.30
1.13
1.06
1.07

Reabsorption which is not included in the litter size number.
CJl
'I

~

TABLE III
MEAN HEASUREMENTS
PERCENT DEATHS OR REABSORPTIONS FOR EACH GROUP

GROUP

Litter

Pup

Size

\Ieight

%Deaths

%Reabsorptiona

(g)

.

I

1.31
+.02

2.0

500mg/kg

7.33
... 46

-----

II
Control

6.75·
:!:·36

1.32
+.02

1.0

-----

III
2000mg/kg

7.00

0

5.0

!·29

1.12
+.04

IV
Control

7.60
:!:·83

1.15
+.04

0

7.0

-

-

-

tn
00

~

TABLE IV

POSTNATAL STUDY
PERCENT OF OFFSPRING ALIVE 3 WEEKS AFTER BIRTH

GROUP

NO. of Pups
Born Alive

NO. of Pups
Alive After 3 Weeks

Control

4o

31

78

500 mg/kg

27

21

78

2000 mg/kg

22

19

86

96 ot Litter
Alive After 3 Weeks

CJ1
(!)

~

TABLE

V

ABNORMALITIES

study

Natal

Groups

Total NO. Offspring
Examined

NO. of Offspring
With Abnormalities

Abnormal! ties •

Group I
500 mg/kg

86

2

(l)Polydactyly-1 extra toe
(l)Missing 1 13th rib

Group II
Control

81

1

(l)Missing 1 sternebrae, 1 cervical vertebrae, 2 13th ribs

Group III
2000 m~/kg

??

2

(2)Fused sternebrae

Group IV
Control

38

1

(1)Halformed Kidney

Control

31

0

500 mg/ke

21

1

2000 mg/kg

19

0

i

Prenatal

Postnatal

•<no.) •

(1)1 eye closed

Number of animals having abnormality in that group

m

0

r
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and one undeveloped embryo in the treated group do not
have much significance when one considers the 86 and 80
offspring, respectively, born alive.

As indicated in Table

III, observations on the number of reabsorptions were not
accounted for in this study.

An accurate assessment of

reabsorptions could not be made because the females were
not sacraficed and their uteruses examined.

Rather it

was felt that a somewhat generalized assessment for
reabsorptions could be made by comparing litter sizes of
the control and amygdalin treated groups as to whether
there was_reduction in litter sizes due to the amygdalin.
In the subsequent study comparing controls and
a 2000 mg/kg group, (Table II), the number of reabsorptions
were identified by careful examination of ±he females
uterus.

The percent of reabsorption was found about the

same for both the control and treated groups.
The incidence of teratogenic anomalies observed
in controls, 500 mg/kg and 2000 mg/kg groups appears to
indicate a lack of the effect of the administered amygdalin
(Table V).

One incident of polydactyly at a dose of 500

mg/kg was that of one extra toe on one foot.

This appears

non-significant because toe malformations are common to
this strain of mice according to Jackson Laboratories where
this strain of mice were obtained.

Only one malformed

f
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kidney was found in these first two studies and it occurred
in a control group.
All other malformations dealt with the mouse's
skeleton.

Wilson (1973) is of the opinion that there is

a great deal of uncertainty in the interpretation of results
due to the spontaneous occurrence of minor anatomical
variations especially the skeleton.

Most mammalian species

have been studied and have found to have anatomical
variations in the segmental patterns of the axial skeleton
especially in the number and morphology of ribs, sternebrae,
lower thoracic and lumbar vertebrae (Wilson, 1973).

They

have been attributed to genotype and to assorted
environmental influences in mice.

In untreated pregnant

mice, rats, rabbits, hamsters, guinea pigs and rhesus
monkeys it is estimated that these skeletal anomalies occur
in 5-15% or more of their offspring (Wilson, 1973).

In

view of these findings the 2 offspring found to have
skeletal anomalies out of all of the offspring examined
having stained bones, from amygdalin treated females,
demonstrates a 2% occurrence and this most likely can not
be attributed to amygdalin treatment.
Sex ratios in this study were approximately 1-1
in controls as well as in all the treated groups.

However,

sex determination at the time of birth is often difficult
and not extremely accurate due to their small size and

r
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variation of speciment sizes within a litter.
The result of a postnatal study {Table IV) involving
the evaluation of behaviorial anomalies showed no
significant difference between the percentage of total
number of offspring alive in each group at the end of the
3 week period between either the control or treated groups.
Examination of the offspring that remained alive at the
end of 3 weeks showed no evidence of any significant
physical or behavioral effects that can be attributed to
amygdalin treatment.
At this time it seems appropriate to mention the
other factors that may lend some error to the interpretation
of the results.

Those factors include insufficient number

of animals, inappropriate species, interpretation of
variations vs. ma1.formations and the time of the year the
experiment was performed.

The response to teratogenic

treatments has been shown to vary quantitatively and
qualitatively at different times of the year in mice {Green,
1966).

There has been an earlier teratogenic rat study
of amygdalin.

However these results have little

significance since data was not available in regards to
number of animals examined, the time or duration of
treatment and whether the kidney abnormalities noted were

r
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characteristic of that rat strain.
This teratology study on mice

was performed because

any clinically used compound should be tested for its effect
on the unborn that may be exposed to it during maternal
treatment.

Both Kreb's "cyanide theory" and Beard's

trophoblast theory of cancer prompted the need for this
investigation.

For if truth exists in these theories,

damage to the unborn could be a great risk for a pregnant
mother on amygdalin therapy.

The negative results found

in this study are in no way designed to disprove one of
these theories.

What these results do tell is that when

mice are given intramuscular injections of amygdalin either
the amygdalin is completely non·-toxic to the embryo and
fetus or due to maternal and/or placental factors amygdalin
at dosages as high as 2000 mg/kg body weight does not reach
the embryo or fetus in high enough concentrations to cause
toxic effects.

If the latter is true perhaps higher dosages

could bring about teratogenic effects.

But due to the

difficulty of obtaining higher dosages of injectable volumes
without denaturing the amygdalin, higher dosages were not
studied.

Multiple daily injections to acquire higher

dosages could also be investigated but stress from many
constant injections to a pregnant mouse may introduce new
statistical variables.

Much more important than the dosage

might be an investigation into a different method of
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administering the amygdalin.

Most of the human clinical

administration of the amygdalin is parenterally which is
why the intramuscular route was chosen for this study.
However, some amygdalin studies seem to indicate toxicity
in adult animals when given orally.

Further teratological

studies using oral administration of amygdalin are thus
clearly needed.

SUMMARY

Amygdalin has been postulated as being selectively
destructive to cancer cells by hydrogen cyanide poisoning
with the control and release of the cyanide by specific
enzyme actions.

Cancer cells and trophoblast cells of

pregnancy are often both described as undifferentiated
cells.

The potential of trophoblast destruction by the

amygdalin was investigated in this study as well as toxicity
to the developing embryo.

Pregnant female mice were

injected intramuscularly with amygdalin through her entire
pregnancy.

Dosages of 500 mg/kg body weight and 20no mg/kg

body weight were administered.

Sectioning and skeletal

staining of the offspring from the treated females indicated
no teratogenic effects were found that were attributed
to the amygdalin.

Litter sizes and average pup weights

of the offspring comparing control and treated groups showed
no significant difference.

A postnatal study allowing

the offspring from control and treated groups to live 3
weeks further substantiated the non-teratogenic effects
of amygdalin at dosages as high as 2000 mg/kg body weight,
to mouse offspring when administered intramuscularly into
pregnant mice.
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